semaglutide restrictions A GLP-1 medication you swallow — no needle, no food — just had its first head-to-head trial results published. Orforglipron (Foundayo, Eli Lilly) was FDA-approved April 2026. In July 2026, the September 2, 2025: U.S. compounding

People often use it to help them lose weight

Note for Formulators: We always recommend that our clients conduct stability and safety testing on their final formulations to comply with local health authority regulations

Plant Physiol 138:16731689 Chen Z, Gallie DR (2004) The ascorbic acid redox state controls guard cell signaling and stomatal movement

A landmark study published in Frontiers in Immunology found that patients with Hashimoto's thyroiditis had significantly altered gut microbiota composition and increased intestinal permeability compared to healthy controls

Visceral hypersensitivity in IBS means that normal amounts of gas feel more painful and uncomfortable